Indefinite Delivery Contract SPE2DR25D9638

The federal contract IDV award is for an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA), valued at $4,999,999 and valid through December 2036. The prime contractor is DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. The contract covers various product categories such as injections, tablets, creams, auto-injectors, and specialty medications, positioning DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain.

The original solicitation was for the DLA Troop Support Medical Supply Chain's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contracts, with an estimated total value of $30.3 billion. The intent was to make multiple awards for separate regions (North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet) to ensure no single primary supplier receives an award for all military pharmaceutical requirements, thereby increasing the Department of Defense's resiliency and access to vital pharmaceuticals during contingencies or natural disasters. This was an unrestricted, fully competitive acquisition using a Lowest Price Technically Acceptable (LPTA) evaluation, with the possibility of a reverse auction to determine the final distribution fees.